Avaí Bio, Inc.
AVAI
$0.33
-$0.02-4.68%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 503.30K | 364.30K | 481.10K | -54.20K | 409.40K |
| Depreciation & Amortization | 6.50K | 6.50K | 6.50K | 15.80K | 19.50K |
| Other Operating Expenses | 44.00K | 58.40K | -- | -425.60K | 23.40K |
| Total Operating Expenses | 553.70K | 453.00K | 487.60K | -464.10K | 452.30K |
| Operating Income | -553.70K | -453.00K | -487.60K | 464.10K | -452.30K |
| Income Before Tax | -553.70K | -453.00K | -487.60K | 464.10K | -452.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -553.70K | -453.00K | -487.60K | 464.10K | -452.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -553.70K | -453.00K | -487.60K | 464.10K | -452.30K |
| EBIT | -553.70K | -453.00K | -487.60K | 464.10K | -452.30K |
| EBITDA | -547.20K | -446.50K | -481.10K | 488.20K | -432.80K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 138.03M | 137.62M | 137.46M | 137.07M | 137.00M |
| Average Diluted Shares Outstanding | 138.03M | 137.62M | 137.46M | 137.07M | 137.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |